Peter Murray, Editor

About the Author Peter Murray, Editor


Oppenheimer Shares Two Cents on Fitbit Inc (FIT) Following 17th Annual Oppenheimer Consumer Conference

Oppenheimer analyst Andrew Uerkwitz weighs in on wearables maker Fitbit Inc (NYSE:FIT), after hosting the company’s VP of IR …

Read more

Rosenblatt Pounds The Table On Advanced Micro Devices, Inc. (AMD), Baird Cheers Amazon.com, Inc. (AMZN) Prime Air Ramp

Advanced Micro Devices and x86 CPU market Rosenblatt analyst Hans Mosesmann is out with a research note …

Read more

Oppenheimer Insights: Advanced Micro Devices, Inc. (AMD) and Cisco Systems, Inc. (CSCO)

Equity research analysts at Oppenheimer are out with research notes on semiconductor giant Advanced Micro Devices, Inc. …

Read more

Goldman Sachs Reiterates a Bullish Stance on Sunrun Inc (RUN); Here’s Why

Sunrun Inc (NASDAQ:RUN) shares rallied on Tuesday following bullish comments from Goldman Sachs analyst Brian K. …

Read more

Amazon.com, Inc. (AMZN) Shares Pop on M&A News; Top Analysts Cheer

Amazon.com, Inc. (NASDAQ:AMZN) shares are up 3% in Friday’s trading session, following the news that …

Read more

This Analyst Sees 200% Upside for Synergy Pharmaceuticals Inc (SGYP)

In a research report released Thursday, Cantor analyst William Tanner initiated coverage on shares of Synergy Pharmaceuticals …

Read more

H.C. Wainwright Initiates Buy on ZIOPHARM Oncology Inc. (ZIOP); Sees 53% Upside for the Stock

In a research report released Thursday, H.C. Wainwright analyst Swayampakula Ramakanth initiated coverage on shares of ZIOPHARM …

Read more

Barrick Gold Corp (USA) (ABX) Is Likely to Divest Its Stake in Acacia: Berenberg

Barrick Gold Corp (USA) (NYSE:ABX) disclosed that up to 10% of its attributable output could …

Read more

Oppenheimer Sees 232% Upside for MEI Pharma Inc (MEIP); Here’s Why

Oppenheimer analyst Leah R. Cann initiated coverage on shares of MEI Pharma Inc (NASDAQ:MEIP) with an …

Read more

Aerie Pharmaceuticals Inc (AERI) Moves a Step Closer to Glaucoma Drug

After market close yesterday, Aerie Pharmaceuticals Inc (NASDAQ:AERI) announced positive 3-month top-line efficacy results from …

Read more